{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:28:30Z","timestamp":1793633310242,"version":"4.5.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo Europe GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.thromres.2026.109614","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:30:28Z","timestamp":1770654628000},"page":"109614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A real-world evaluation of the safety of edoxaban in frail older adults with non-valvular atrial fibrillation"],"prefix":"10.1016","volume":"259","author":[{"given":"Alvaro","family":"Hermida-Ameijeiras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3227-8990","authenticated-orcid":false,"given":"Nestor","family":"Vazquez-Agra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rodriguez-Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo-Abel","family":"Cedeno-Veloz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Baeza-Trinidad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Solla-Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Bosco","family":"Lopez-Saez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Gomez-Huelgas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago-Jesus","family":"Freire-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Balanza-Garzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Roqueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pose-Reino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2026.109614_bb0005","first-page":"e1","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"26","author":"Van Gelder","year":"2025","journal-title":"G. Ital. Cardiol. (Rome)"},{"key":"10.1016\/j.thromres.2026.109614_bb0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bmj.39280.660567.55","article-title":"Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial","volume":"335","author":"Fitzmaurice","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2026.109614_bb0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ageing\/afy180","article-title":"Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis","volume":"48","author":"Wilkinson","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.thromres.2026.109614_bb0020","series-title":"Epidemiology and Treatment of Atrial Fibrillation","article-title":"Anticoagulation in AF and elderly frail patient: how to face new challenges","author":"Grille","year":"2019"},{"key":"10.1016\/j.thromres.2026.109614_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2010.08.009","article-title":"The frailty syndrome: definition and natural history","volume":"27","author":"Xue","year":"2011","journal-title":"Clin. Geriatr. Med."},{"key":"10.1016\/j.thromres.2026.109614_bb0030","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0047-6374(02)00082-9","article-title":"The mortality rate as a function of accumulated deficits in a frailty index","volume":"123","author":"Mitnitski","year":"2002","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.thromres.2026.109614_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejim.2016.08.002","article-title":"CRONIGAL: prognostic index for chronic patients after hospital admission","volume":"36","author":"Su\u00e1rez-Dono","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.thromres.2026.109614_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-30610-2","article-title":"Atrial fibrillation as a new prognosis factor in chronic patients after hospitalization: the CHRONIBERIA index","volume":"13","author":"Suarez-Dono","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2026.109614_bb0045","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2026.109614_bb0050","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2026.109614_bb0055","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/STROKEAHA.116.016275","article-title":"Rivaroxaban versus dabigatran or warfarin in real-world studies of stroke prevention in atrial fibrillation: systematic review and meta-analysis","volume":"48","author":"Bai","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2026.109614_bb0060","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.amjcard.2019.02.060","article-title":"Meta-analysis of direct-acting oral anticoagulants compared with warfarin in patients >75 years of age","volume":"123","author":"Malik","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2026.109614_bb0065","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.semerg.2020.02.001","article-title":"Why are antithrombotic drugs not prescribed to octogenarian patients with atrial fibrillation at risk of stroke?","volume":"46","author":"Formiga","year":"2020","journal-title":"Semergen"},{"key":"10.1016\/j.thromres.2026.109614_bb0070","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of oral anticoagulants in atrial fibrillation: a systematic review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2026.109614_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003432","article-title":"Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial","volume":"5","author":"Kato","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2026.109614_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2026.109614_bb0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2026.109614_bb0090","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jamda.2017.07.005","article-title":"FRAIL questionnaire screening tool and short-term outcomes in geriatric fracture patients","volume":"18","author":"Gleason","year":"2017","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.thromres.2026.109614_bb0095","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109614_bb0100","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2026.109614_bb0105","first-page":"704","article-title":"Health care to frail elderly: from theory to scientific evidence","volume":"115","author":"Bazt\u00e1n Cort\u00e9s","year":"2000","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.thromres.2026.109614_bb0110","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12916-018-1223-3","article-title":"Fifteen years of progress in understanding frailty and health in aging","volume":"16","author":"Rockwood","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.thromres.2026.109614_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2021.100070","article-title":"Edoxaban dosing patterns in real life practice \u2013 results from the DRESDEN NOAC REGISTRY","volume":"5","author":"Beyer-Westendorf","year":"2021","journal-title":"Thromb. Updat."},{"key":"10.1016\/j.thromres.2026.109614_bb0120","article-title":"Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry","volume":"14","author":"Guo","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.thromres.2026.109614_bb0125","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28500","article-title":"Outcomes and safety of very-low-dose edoxaban in frail patients with atrial fibrillation in the ELDERCARE-AF randomized clinical trial","volume":"5","author":"Akashi","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.thromres.2026.109614_bb0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/ehjqcco\/qcad019","article-title":"Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study","volume":"10","author":"Grymonprez","year":"2024","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"10.1016\/j.thromres.2026.109614_bb0135","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.4022\/jafib.1870","article-title":"What is the impact of frailty on prescription of anticoagulation in elderly patients with atrial fibrillation? A systematic review and meta-analysis","volume":"10","author":"Oqab","year":"2018","journal-title":"J. Atr. Fibrillation"},{"key":"10.1016\/j.thromres.2026.109614_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-020-01870-w","article-title":"Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial","volume":"18","author":"Wilkinson","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.thromres.2026.109614_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100569","article-title":"Very elderly patients with atrial fibrillation treated with edoxaban: impact of frailty on outcomes","volume":"2","author":"Denas","year":"2023","journal-title":"JACC Adv."},{"key":"10.1016\/j.thromres.2026.109614_bb0150","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1136\/heartjnl-2020-317923","article-title":"Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation","volume":"107","author":"Hanon","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2026.109614_bb0155","first-page":"566","article-title":"Real-world comparison of non-vitamin K antagonist oral anticoagulants and warfarin in Asian octogenarian patients with atrial fibrillation","volume":"13","author":"Kwon","year":"2016","journal-title":"J. Geriatr. Cardiol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826000332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:48:59Z","timestamp":1793630939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826000332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":31,"alternative-id":["S0049384826000332"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109614","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A real-world evaluation of the safety of edoxaban in frail older adults with non-valvular atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109614"}}